Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome

详细信息    查看全文

• 作者：Kalliopi Kotsa ; Maria P. Yavropoulou ; Olympia Anastasiou ; John G. Yovos
• 关键词：Vitamin D₃ treatment ; PCOS insulin sensitivity ; insulin resistance ; lipid profile
• 刊名：Fertility and Sterility
• 出版年：2009
• 出版时间：September 2009
• 年：2009
• 卷：92
• 期：3
• 页码：1053-1058
• 全文大小：130 K

文摘

Objective

To determine the effect of treatment with vitamin D₃ analogue in the parameters of glucose metabolism in obese women with polycystic ovary syndrome (PCOS).

Design

Observational study.

Setting

Obese women with PCOS in an academic research environment.

Patient(s)

Fifteen obese women (mean age 28 ± 1.3 years, mean body mass index 32.55 ± 0.43) with documented chronic anovulation and hyperandrogenism were recruited into the study.

Intervention(s)

Alphacalcidol (1-α-hydroxyvitamin D₃) was administered orally 1 μg/day for 3 months. All subjects underwent a frequently sampled IV glucose tolerance test after a 10- to 12-hour overnight fast during a spontaneous bleeding episode before and after treatment with alphacalcidol.

Main Outcome Measure(s)

Peripheral insulin resistance and insulin effectiveness were estimated with minimal model.

Result(s)

The first phase of insulin secretion was significantly increased after treatment with alphacalcidol. A favorable statistically significant change also was observed in the lipid profile.

Conclusion(s)

Treatment with the vitamin D₃ analogue (alphacalcidol) could be of value in the management of PCOS.